Northern's Q4 Earnings Lag Estimates, Revenues Increase Y/Y — Negative

NOG   Zacks Investment Research — February 21, 2025

NOG expects annual oil production in the range of 75,000-79,000 barrels per day and total production in the band of 130,000-135,000 Boe/d for 2025.

image for news Northern's Q4 Earnings Lag Estimates, Revenues Increase Y/Y

PagSeguro Digital Ltd. (PAGS) Q4 Earnings and Revenues Beat Estimates — Positive

PAGS   Zacks Investment Research — February 21, 2025

PagSeguro Digital Ltd. (PAGS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share.

image for news PagSeguro Digital Ltd. (PAGS) Q4 Earnings and Revenues Beat Estimates

Coinbase said on Friday the U.S. securities regulator planned to withdraw its lawsuit against the crypto exchange, ending a contentious years-long legal battle once considered existential for the trading platform and the broader sector.

image for news US securities regulator to drop lawsuit against Coinbase, exchange says

Palantir Stock Skids—How Much Further Can It Fall? — Neutral

PLTR   MarketBeat — February 21, 2025

Shares of Palantir Technologies Inc. NASDAQ: PLTR are down 17% in two trading sessions. For much of the last 18 months, Palantir has been like a boxer who continues to have opponents throw punches, none of which land with any effect.

image for news Palantir Stock Skids—How Much Further Can It Fall?

AI-Driven Advertising Has AppLovin Soaring — Positive

APP   FXEmpire — February 21, 2025

Shares of AppLovin, Corp. (APP), which operates a marketing platform and makes mobile apps, are up 685% in a year.

image for news AI-Driven Advertising Has AppLovin Soaring

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business o.

image for news Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025

2 S&P 500 ETFs for Growth and Leverage in a Hot Market — Neutral

SPUU  SPYG   MarketBeat — February 21, 2025

To put it mildly, it's been a very good couple of years for the S&P. Following a tepid 2022, the banner S&P 500 index has accelerated growth from 2023 into 2024.

image for news 2 S&P 500 ETFs for Growth and Leverage in a Hot Market

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? — Neutral

RXRX   MarketBeat — February 21, 2025

Recursion Pharmaceuticals' NASDAQ: RXRX stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken by artificial intelligence (AI) chip giant NVIDIA NASDAQ: NVDA. A recent SEC filing showed NVIDIA reshuffling its AI investment portfolio, and while it trimmed its holdings in several AI ventures, it notably maintained its stake in Recursion Pharmaceuticals.

image for news Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite?

The e-commerce stock has started 2025 on a tear, with investors betting that China's faltering economy will rebound.

image for news GameStop CEO Ups Alibaba Bet to $1 Billion. Why Earnings Wowed the Street.

Gold Mining ETF (GDXJ) Hits New 52-Week High — Positive

GDXJ   Zacks Investment Research — February 21, 2025

For investors seeking momentum, VanEck Junior Gold Miners ETF GDXJ is probably on the radar. The fund just hit a 52-week high and is up about 80% from its 52-week low price of $31.00/share.

image for news Gold Mining ETF (GDXJ) Hits New 52-Week High

RESTON, Va. , Feb. 21, 2025 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) ("Holdings") today announced that the previously announced offer by its wholly-owned subsidiary, Leidos, Inc. ("Leidos") to purchase for cash (the "Tender Offer") any and all of its outstanding 3.625% Senior Notes due 2025 (the "2025 Notes") expired at 5:00 p.m.

image for news Leidos, Inc. Announces the Expiration and Results of Cash Tender Offer for Any and All 3.625% Senior Notes Due 2025

Redfin Report: The 10 Most Expensive Home Listings in the U.S. — Neutral

RDFN   Business Wire — February 21, 2025

SEATTLE--(BUSINESS WIRE)-- #housingmarket--(NASDAQ: RDFN) — Half of the nation's 10 most expensive home listings are in coastal Florida, three are in Southern California, one is in New York City and one is in Lake Tahoe. That's according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. All 10 listings are asking more than $100 million—and two are asking more than $200 million. Though many Florida residents are grappling with the increasing frequency of natural disasters an.

image for news Redfin Report: The 10 Most Expensive Home Listings in the U.S.

Only 19% of communications service providers worldwide have fully implemented an integrated set of processes, platforms and governance policies required to support effective data modernization for AI JERSEY CITY, NJ / ACCESS Newswire / February 21, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today released the findings of a comprehensive global study conducted by International Data Corporation (IDC), sponsored by Amdocs. The IDC white paper*, "AI Demands More: Enterprises Are Playing Catch-Up on Mission-Critical Data Modernization," highlights the critical need for robust data modernization efforts to fully leverage the power of …

image for news Study: Over 75% of Service Providers Believe Investment in Data Modernization Crucial to Realizing Generative AI's Full Potential

MIAMI, FLORIDA / ACCESS Newswire / February 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) (Ag⁺) and the highly reactive Silver(II) (Ag²⁺) in a biologically compatible form. This milestone overcomes a major limitation in silver-based medical applications, opening the door for advanced antimicrobial treatments, wound care solutions, and infection-resistant medical coatings.

image for news Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market

Dates Set for PG&E Quarterly Stock Dividends — Neutral

PCG   PRNewsWire — February 21, 2025

OAKLAND, Calif. , Feb. 21, 2025 /PRNewswire/ -- On February 20, 2025, PG&E Corporation (NYSE: PCG) declared its first quarter 2025 regular cash dividend of $0.025 per share on the Corporation's common stock.

image for news Dates Set for PG&E Quarterly Stock Dividends

Elanco to Participate in Upcoming Investor Conferences — Neutral

ELAN   PRNewsWire — February 21, 2025

GREENFIELD, Ind. , Feb. 21, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.

image for news Elanco to Participate in Upcoming Investor Conferences

SAN FRANCISCO--(BUSINESS WIRE)--Twilio (NYSE: TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, today announced that Chief Executive Officer Khozema Shipchandler will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on Tuesday, March 4, 2025 at 8:30 a.m. (PT) / 11:30 a.m. (ET). A live webcast and replay will be available on Twilio's investor relations website at investors.twilio.com.

image for news Twilio to Participate in Morgan Stanley Technology, Media & Telecom Conference

SAN DIEGO , Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which Neurocrine Biosciences may repurchase up to $500 million of its shares, subject to market conditions. This new share repurchase authorization is in addition to the $300 million accelerated repurchase program that was announced in October 2024 and completed in early February 2025.

image for news Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program

AUSTIN, Texas, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Big Path Capital has honored Vital Farms (Nasdaq: VITL) and its President & CEO Russell Diez-Canseco at #2 on the annual MO 100 Top Impact CEO Ranking. This is the fourth consecutive year the company and Diez-Canseco have been honored, moving up from the #3 spot in 2024 to the #2 spot this year.

image for news Vital Farms and Its President & CEO Russell Diez-Canseco Recognized for “Catalyzing Positive Social and Environmental Change” on Big Path Capital's 2025 MO 100 Top Impact CEO Ranking

CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET.

image for news Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference